Advancing Lung Cancer Management

Advancing Lung Cancer Management
Online Conference, 3.5 CPD hours
Wed 9 Sep 2026

This online, free-to-attend course was designed for NHS Professionals working in lung cancer services. 

This course explored how to deliver an effective service that maximised quality of life while optimising patient pathways. Attendees developed their practice, heard updates on the latest research and developments, and gained insights to support improved patient outcomes.

Sponsored by:    


This meeting was sponsored by Regeneron. Regeneron had no input into the meeting agenda, with the exception of any Regeneron sponsored session which is highlighted on the agenda tab.

Improving your practice

Enhancing your knowledge with expert led, structured NHS learning 

Attendees developed their knowledge and experience, gaining practical takeaways to improve lung cancer patient pathways by focusing on:

  • Identifying new opportunities with sub-cutaneous immunotherapy 
  • Integrating new treatments while managing service capacity 
  • Delivering therapies safely across different service setups 
  • Introducing new drugs effectively into patient pathways 
  • Optimising CNS workload and team efficiency 
  • Streamlining lung cancer pathways post-screening 
  • Enhancing quality of life through pain and survivorship care

Online learning

Developed with convenience in mind, this online forum enabled attendees to participate remotely.

Attendees gained actionable insights into lung cancer treatment, research and optimising a patient-led approach. They:

  • Deepened their understanding of immunotherapy, newly licensed drugs and their administration
  • Connected with peers, shared experiences and exchanged practical insights to strengthen lung cancer care
  • Developed practical skills to improve pain management and quality of life for lung cancer patients
  • Applied their knowledge and shared specialist advice through case studies and facilitated interactive breakout discussions, supporting improvements in workload and capacity management

Confirmed sponsor

SBK Healthcare would like to thank Regeneron for sponsoring this educational forum.


This meeting was sponsored by Regeneron. Regeneron had had no input into the meeting agenda, with the exception of any Regeneron sponsored session which is highlighted on the agenda tab.

Learning & development

Oncology National Networking Forums are pleased to be featured on the ACCEND Greater Manchester ePortfolio

The ePortfolio platform is available via the Greater Manchester Cancer Academy and supports professional development in cancer care.

This forum and all of our events are mapped to the ACCEND Framework and can be recorded in the Greater Mancester ePortfolio to help you evidence your learning, reflections and competencies.

To find out more, click on the ACCEND tab.

8:30
Join, tech support and opportunity to network in your breakout rooms
9:00
Chair’s opening remarks and introductions
Venencia Rayson, Lead Specialist Nurse, Lung Cancer and EBUS Services, Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust
Patient centered treatment
Regeneron Sponsored Presentation
  • This is a promotional session funded and organised by Regeneron UK. Prescribing information will be available at the meeting. Attendance is only for HCPs and is optional.
9:10
Rethinking First-Line Treatment in Advanced NSCLC: Why the Choice of IO + Chemotherapy in PD-L1–Positive Disease Matters
Dr Sean Dulloo, Consultant Medical Oncologist, University Hospitals of Leicester NHS Trust and Dr Farasat Kazmi, Consultant Clinical Oncologist, Norfolk & Norwich University Hospitals NHS Foundation Trust
10:10
Questions and answers with Dr Sean Dulloo and Dr Farasat Kazmi
End of Regeneron Sponsored Presentation
10:20
Meet the Regeneron team
10:30
Screen break
10:40
Interactive discussion: Navigating new drug introduction and effective administration
  • How could the introduction of maximised subcutaneous immunotherapy impact your day-to-date practice and the patient pathway? How is your service preparing?
  • Does your service have an aseptic unit? If not, what type of support would be valuable to you to deliver the treatment safely?
  • How could these new treatment options affect patient outcomes and their overall experience?
10:55
Feedback from interactive session: Navigating new drug introduction and effective administration
Sub-cutaneous Immunotherapy treatment
11:00
Understanding sub-cutaneous immunotherapy in lung cancer
  • Investigating new treatment possibilities with sub-cutaneous immunotherapy
  • Navigating treatment options: understanding the impact on hospital capacity and day therapy units
  • Exploring delivery in services with aseptic units versus those without: drug availability and administration processes
Mark Pearce, Specialist Clinical Pharmacist, The Christie NHS Foundation Trust
Enhancing Patient Pathways
11:30
Optimising lung cancer pathways and managing service demand following screening
  • Exploring the performance and outcomes of the NHS Lung Cancer Screening Plan: measuring the outcome on lung cancer services
  • Understanding the gold standard framework for lung cancer patient pathways and how to achieve it
  • Managing workload within your team to ensure efficient patient pathways following screening
Helen Lyttle, Lung Cancer Screening Programme Manager, TIC Health
12:00
Questions and answers with your speaker
12:10
Interactive session: Improving support for lung cancer survivors
  • How do you currently ensure a smooth transition between treatment and post-treatment care? What are you working on to improve the process?
  • Which external support systems do you currently signpost your patients to?
  • What do your patients tell you is important for them in survivorship care?
Pain management
12:25
Feedback from interactive discussion: Improving support for lung cancer survivors
12:30
Improving pain management to improve quality of life for lung cancer patients
  • Understanding how to manage pain for late-stage and complex patients undergoing radical treatment
  • Bettering follow-up care for lung cancer survivors to enhance quality of life
  • Managing side-effects of medication whilst still enhancing patient outcomes
Martin Galligan, Senior Lecturer, The Royal Marsden School
1:00
Questions and answers with your speakers
1:10
Close of day

With thanks to the speakers

Venencia Rayson

Lead Specialist Nurse, Lung Cancer and EBUS Services, Committee member @ LCNUK
Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust
user icon

Mark Pearce

Specialist Clinical Pharmacist
The Christie NHS Foundation Trust
user icon

Helen Lyttle

Lung Cancer Screening Programme Manager
TIC Health
user icon

Martin Galligan

Senior Lecturer
The Royal Marsden School
user icon

Dr Farasat Kazmi

Consultant Clinical Oncologist
Norfolk & Norwich University Hospitals NHS Foundation Trust
user icon

Dr Sean Dulloo

Consultant Medical Oncologist
University Hospitals of Leicester NHS Trust

Who came?

This online meeting was ideal for NHS professionals working with individuals with lung cancer. We were joined by the likes of: 

  • Clinical Nurse Specialists 
  • Oncology Consultants 
  • Respiratory Consultants 
  • Pharmacists 
  • Cancer Service Managers 
  • Research and Screening Professionals 
  • Oncology Physiotherapists
  • Palliative Care Consultants 
  • Palliative Nurse Specialists

Past attendee feedback

Over the past lung cancer events, we have received positive feedback from attendees, who learn from our expert speakers, but appreciate the interactive aspects to improve their practice as a whole. Hear how previous attendees have benefited from our well-rounded agenda: 

quote icon
“Really appreciated the opportunity for new learning, but also value the time to share ideas, and support other nurses based in caring for patients with lung cancer”
- Cornwall Partnership NHS Foundation Trust, Progressing Your Lung Cancer Service, March 2024
quote icon
“Very informative and interesting, good to hear what other trusts are doing”
- Dorset County Hospital NHS Foundation Trust, Progressing Your Lung Cancer service, March 2024
quote icon
“Interesting day, good to collaborate with interesting talks”
- NHS Greater Glasgow and Clyde Hospital, Progressing Your Lung Cancer Service, March 2024
quote icon
“Very relevant to my practice, and benefitted from knowledgeable experts”
- NHS Epsom and St Helier University Hospital, Improving Interstitial Lung Disease Pathways and Management, December 2025
quote icon
“Very informative, and I enjoyed the interactive breakout sessions!”
- North Cumbria Integrated Care NHS Trust, Improving Interstitial Lung Disease Pathways and Management, December 2025
quote icon
“I have certainly come away with some ideas for nurse-led clinics”
- Great Western Hospitals, NHS Foundation Trust, Improving Lung Disease Pathways and Management, December 2025

About the ACCEND Framework

The ACCEND Framework is designed to enhance cancer care by providing a structured approach to education and professional development for healthcare professionals.

  • It defines the essential Cancer Capabilities in Practice (CiPs) and offers a tailored educational structure to support progression at every stage of a cancer care career.
  • Launched in January 2023, the framework aims to transform career pathways and improve training and development opportunities across the cancer workforce.
  • It provides access to the education and training needed to meet role-specific competencies and includes dedicated resources for nurses, allied health professionals and those in cancer-related support roles.
  • The ACCEND Framework delivers a nationally agreed career and education structure underpinned by clearly defined capabilities in practice.

Map your learning

All Oncology National Networking Forum courses listed on the ACCEND Greater Manchester ePortfolio are fully aligned with the ACCEND Framework.

You can easily log your attendance and map your learning to the Cancer Capabilities in Practice (CiPs) through the ACCEND Greater Manchester ePortfolio.

To do this:

  • Register and log in to the Greater Manchester ePortfolio
  • Click ‘Add Entry’
  • Select 'Choose an item from the library'
  • Change the provider to Oncology National Networking Forums
  • Choose the relevant event you have attended (or plan to attend)

This tool offers a central space to track your professional development, reflections and achievements - supporting your ongoing career in cancer care.

Click here to access the Greater Manchester ePortfolio


With thanks to the sponsor


Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases, in oncology, immunology, eye disease, cardiometabolic and neurological conditions. Founded and led by physician-scientists, we repeatedly and consistently turn science into medicine.

This meeting was sponsored by Regeneron. Regeneron had had no input into the meeting agenda, with the exception of any Regeneron sponsored session which is highlighted on the agenda tab.

Your event, managed by us

SBK Healthcare also provides in-house forums. Working closely with you as the client we can research, produce, market and deliver the conference or online forum that best suits the audience and meets your goals.

Reach out today

If you would like more information on our sponsorship options an in-house forum or if you wish to discuss your needs and what solutions may be appropriate for your business, please contact:

Vanessa Jarman
Contact: 01732 897788
Email: Vanessa.Jarman@sbk-healthcare.co.uk